AAD 2026Abstract 76791
Efficacy of sarecycline in the treatment of moderate-to-severe facial acne vulgaris (AV)
Combined results from three phase 3 studies
Del Rosso J, Gold LS, Zhang J, Li H, Callender V, Dale G, Green L, Weiss J, Bentohami A, Robles JC, Tomondy P, Tan J
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: AcneAntimicrobials
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.785 · Not in PubMed: details from Crossref